N07AA30 - Ambenonium |
Propably not porphyrinogenic |
PNP |
Rationale
Probably non-oxidative metabolism. No data pointing to CYP-interaction.
Chemical description
(To be edited, initial data ST OCT 04) Cholinesterase inhibitor of long duration (5-8 hours) used in myasthenia gravis. No data pointing to CYP-interaction.
Similar drugs
© NAPOS 2024